WSJ.com: US Business

AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials
The success of the vaccine being developed by the University of Oxford and AstraZeneca bodes well for the near-term availability of a third treatment for Covid-19, joining those from Moderna as well as Pfizer and BioNTech.

Merck to Buy OncoImmune for $425 Million Amid Race for Covid-19 Treatments
The drugmaker is buying biopharmaceutical company OncoImmune, which has reported positive results from a late-stage study of a coronavirus therapeutic candidate, for $425 million in cash.

GM Stops Backing Trump Administration in Emissions Fight With California
General Motors will no longer back the administration in its legal battle to strip California?s authority to set its own fuel-efficiency regulations, saying GM?s goals for green cars are aligned with the state and the new Biden administration.

GM to Recall 5.9 Million Vehicles With Takata Air-Bag Inflaters
General Motors has agreed to replace potentially faulty Takata air-bag inflaters in millions of its pickups and SUVs, a fix ordered by federal safety regulators that could cost the auto maker more than $1 billion.

Amid Coronavirus Surge, Holiday Shoppers Flock to Malls
Americans visited malls over the weekend saying they wanted to do Christmas shopping before potential lockdown restrictions are implemented or to avoid Black Friday crowds, as the spreading coronavirus looms over the holiday season.

Biden Picks Janet Yellen for Treasury Secretary
President-elect Joe Biden plans to nominate former Federal Reserve Chairwoman Janet Yellen, an economist at the forefront of policy-making for three decades, to become the next Treasury secretary.

U.S. Economic Activity Picks Up on Postelection Lift, Vaccine Results
The U.S. economy continues to recover from the downturn caused by the pandemic, according to business surveys that show services and manufacturing activity growing, while surveys show the European economy is set for a fresh contraction in the final quarter of 2020.